Gabriella Santuccio

Catania, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study.

The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study.

Journal: Frontiers in pharmacology

Published: December 05, 2025

Clinical, genomic, and functional characterization of vancomycin-resistant Enterococci from immunocompromised patients: insights into epithelial dysfunction and bloodstream infections.

Clinical, genomic, and functional characterization of vancomycin-resistant Enterococci from immunocompromised patients: insights into epithelial dysfunction and bloodstream infections.

Journal: Frontiers in cellular and infection microbiology

Published: October 15, 2025

Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study.

Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study.

Journal: European journal of haematology

Published: August 26, 2025

Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.

Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 22, 2025

Emergencies in Hematology: Why, When and How I Treat?

Emergencies in Hematology: Why, When and How I Treat?

Journal: Journal of clinical medicine

Published: November 08, 2024

Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real-Life Case Series and Literature Review.

Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real-Life Case Series and Literature Review.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: August 14, 2024

Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey.

Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey.

Journal: Annals of hematology

Published: January 16, 2024

Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma.

Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma.

Journal: Cancers

Published: January 13, 2024

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 17, 2022

Dealing with highly active multiple sclerosis after natalizumab-associated PML: could rituximab be of help?

Dealing with highly active multiple sclerosis after natalizumab-associated PML: could rituximab be of help?

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 27, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026